Randomized, Double-Blind Trial of Triple Therapy With Saxagliptin Add-on to Dapagliflozin Plus Metformin in Patients With Type 2 Diabetes

Stephan Matthaei, Doina Catrinoiu, Aleksander Celiński, Ella Ekholm, William Cook, Boaz Hirshberg, Hungta Chen, Nayyar Iqbal, Lars Hansen

Open source

DOI
10.2337/dc15-0811
Published
2015-08-31
Container
Diabetes Care
Publisher
American Diabetes Association
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2337/dc15-0811,
  title = {Randomized, Double-Blind Trial of Triple Therapy With Saxagliptin Add-on to Dapagliflozin Plus Metformin in Patients With Type 2 Diabetes},
  author = {Stephan Matthaei and Doina Catrinoiu and Aleksander Celiński and Ella Ekholm and William Cook and Boaz Hirshberg and Hungta Chen and Nayyar Iqbal and Lars Hansen},
  year = {2015},
  journal = {Diabetes Care},
  doi = {10.2337/dc15-0811},
  url = {https://doi.org/10.2337/dc15-0811}
}

RIS

TY  - JOUR
TI  - Randomized, Double-Blind Trial of Triple Therapy With Saxagliptin Add-on to Dapagliflozin Plus Metformin in Patients With Type 2 Diabetes
AU  - Stephan Matthaei
AU  - Doina Catrinoiu
AU  - Aleksander Celiński
AU  - Ella Ekholm
AU  - William Cook
AU  - Boaz Hirshberg
AU  - Hungta Chen
AU  - Nayyar Iqbal
AU  - Lars Hansen
PY  - 2015
JO  - Diabetes Care
DO  - 10.2337/dc15-0811
UR  - https://doi.org/10.2337/dc15-0811
ER  - 

APA

Matthaei, S., Catrinoiu, D., Celiński, A., Ekholm, E., Cook, W., Hirshberg, B., Chen, H., Iqbal, N., & Hansen, L. (2015). Randomized, Double-Blind Trial of Triple Therapy With Saxagliptin Add-on to Dapagliflozin Plus Metformin in Patients With Type 2 Diabetes. Diabetes Care. https://doi.org/10.2337/dc15-0811

Source records